GKOS vs MET · rev $336.2M vs P/E 13, rev $38.23B
Glaukos Corp (GKOS) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Glaukos Corp (GKOS) is a medical devices company listed on NYSE.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported GKOS revenue for 2026-06-30 was $336.2M. Net income was -$38.2M. GKOS currently screens at market cap $7.63B.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
GKOS currently screens at market cap $7.63B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the GKOS and MET stock pages for the full models.
Not investment advice.